<SEC-DOCUMENT>0001140361-21-020110.txt : 20210607
<SEC-HEADER>0001140361-21-020110.hdr.sgml : 20210607
<ACCEPTANCE-DATETIME>20210607203017
ACCESSION NUMBER:		0001140361-21-020110
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210603
FILED AS OF DATE:		20210607
DATE AS OF CHANGE:		20210607

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Meiers James R.
		CENTRAL INDEX KEY:			0001860603

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38594
		FILM NUMBER:		211000973

	MAIL ADDRESS:	
		STREET 1:		C/O TILRAY, INC.
		STREET 2:		745 FIFTH AVENUE, SUITE 160
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10151

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tilray, Inc.
		CENTRAL INDEX KEY:			0001731348
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				824310622
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		745 FIFTH AVENUE
		STREET 2:		SUITE 1602
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10151
		BUSINESS PHONE:		519.322.8800

	MAIL ADDRESS:	
		STREET 1:		745 FIFTH AVENUE
		STREET 2:		SUITE 1602
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10151
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2021-06-03</periodOfReport>

    <issuer>
        <issuerCik>0001731348</issuerCik>
        <issuerName>Tilray, Inc.</issuerName>
        <issuerTradingSymbol>TLRY</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001860603</rptOwnerCik>
            <rptOwnerName>Meiers James R.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O TILRAY, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>745 FIFTH AVENUE, SUITE 1602</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10151</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>true</isOfficer>
            <officerTitle>Head of Canada</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Class 2 Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2021-06-03</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>23826</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>19.64</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.54 to $19.70, inclusive. The reporting person undertakes to provide to Tilray, Inc., any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Carl A. Merton, as Attorney-in-Fact for James R. Meiers</signatureName>
        <signatureDate>2021-06-07</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
